Sanofi is a global healthcare company focused on pharmaceuticals and vaccines. Its core products include prescription medications for diabetes, cardiovascular diseases, and oncology, as well as vaccines for infectious diseases. Major business segments comprise Pharmaceuticals, Vaccines, and Consumer Healthcare. The primary revenue sources are from innovative medicines and vaccine sales, with a growing emphasis on specialty care and biologics.
The investment profile of Sanofi is more aligned with value investors, given its established market presence and stable revenue streams. The company may appeal to those seeking a balanced approach, as it combines growth potential with a focus on sustainable earnings. The stock is suitable for investors with a medium to long-term horizon, offering moderate liquidity.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-08-09 | Hold | Buy | Stable dividend, but mixed momentum and performance signals. |
| 2026-08-04 | Buy | Hold | Weak momentum and high risk offset dividend yield. |
| 2026-08-02 | Hold | Buy | Stable dividends, but mixed momentum and performance signals. |
| 2026-07-27 | Sell | Hold | Weak fundamentals and negative momentum raise concerns. |
| 2026-07-05 | Hold | Sell | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-06-27 | — | Hold | Weak fundamentals and negative momentum raise concerns. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-07-08 | Morgan Stanley | Target Lowered | 52 → 49 | 42.98 |
| 2026-05-01 | Morgan Stanley | Rating Downgraded | — → 52 | 46.08 |
| 2026-04-20 | BNP Paribas | Rating Downgraded | — → 50 | 48.06 |
